The European buy and build market has experienced very low activity levels and deal values in quarter one 2014 dragging down half year figures, according to figures released by Silverfleet Capital and Mergermarket. The European Buy & Build Monitor for H1 2014, which tracks add-on activity undertaken by European companies
The gradual economic improvement in Europe, increasingly liquid debt markets and stronger IPO market conditions supported an increase in exit activity of PE-backed businesses in 2013. That’s according to EY’s ninth annual European PE exits study. Last year saw 77 exits in the population covered by the study versus 61
Venture capital (VC) funding for the life sciences sector, which includes biotechnology and medical devices, reached USD2.5 billion in 195 deals for the second quarter of 2014, according to a report. The report, which includes data from the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA),
An anticipated rise in interest rates is accelerating the use of alternative investments by insurance general accounts, according to research from Cerulli Associates.

 "Although they comprise a relatively small portion of total assets, large insurance companies have been known for their direct investments in private equity, real estate, and infrastructure,"
High net worth (HNW) women are turning to non-traditional investments as they look to generate income, drive capital growth, and achieve portfolio diversification. These are among the latest findings from “Investing Outside the Box”, a study on trends in non-traditional investing from MainStay Investments, a New York Life company.
The UK has overtaken Germany as the European country in which most research and development (R&D) takes place, according to second annual CMS Employee Inventor Rewards Survey. A key question raised by the survey is the extent to which rewards actually encourage inventions and innovation among employees. A third
Growth capital investor Beringea’s portfolio company Abzena Plc, previously known as Polytherics, has raised GBP20 million by way of a placing of 25 million new ordinary shares at 80 pence per share. The firm’s ordinary shares have been admitted to trading on the AIM market of the London Stock Exchange.
Since 2008 nearly one-third of European charities have restructured their investment portfolios to increase their exposure to alternative products, according to a survey by Cerulli Associates. The latest issue of The Cerulli Edge-Global Edition includes the results of a survey of major European charities which, together, hold a total of GBP64.2
International companies continue to turn to US stock exchanges to connect with American investors for their IPOs and subsequent capital raising, according to BNY Mellon's Depositary Receipts 2014 Midyear Update. The first half of 2014 saw the highest level of DR capital raisings in the last three years. As of
Private equity firm Consonance Capital Partners (CCP) has held the final closing of its USD500 million healthcare private equity fund. The fund was oversubscribed, surpassing its USD350 million target and reaching its fundraising cap of USD500 million. Consonance Capital Partners invests in private companies in the lower middle market
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
